Depletion of the aryl hydrocarbon receptor in MDA-MB-231 human breast cancer cells altered the expression of genes in key regulatory pathways of cancer

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Goode, Gennifer ^a   Pratap, Siddharth ^a   Eltom, Sakina E ^a  

^a MEHARRY MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; CALVASCULIN; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; MUCIN 1; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 3; PROTEIN BCL 3; TRYPTOPHAN; VASCULOTROPIN A; MESSENGER RNA; SMALL INTERFERING RNA; TUMOR MARKER;

ABCC3 GENE; ABI3 GENE; ANGIOGENESIS; ARTICLE; BCL3 GENE; BIRC3 GENE; BREAST CANCER; C15ORF48 GENE; CALB1 GENE; CANCER CELL; CANCER GROWTH; CCL2 GENE; CD74 GENE; CELL GROWTH; CELL INVASION; CELL MIGRATION; CELL SURVIVAL; CONTROLLED STUDY; CSF1 GENE; DOWN REGULATION; DPP4 GENE; GENE; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE MUTATION; GENE REGULATORY NETWORK; GENE SILENCING; HLA DPA1 GENE; HLA DRA GENE; HUMAN; HUMAN CELL; IL18 GENE; IL8 GENE; KYNU GENE; MAMDC2 GENE; MRGPRX4 GENE; MUC1 GENE; MULTIDRUG RESISTANCE; NAALADL2 GENE; PHENOTYPIC VARIATION; PLEKHA7 GENE; PROTEIN DEPLETION; PSG2 GENE; S100A4 GENE; SAMSN1 GENE; SERPINB2 GENE; SNACAIP GENE; SPRR2A GENE; TNIP3 GENE; TRYPTOPHAN METABOLISM; UPREGULATION; ANTAGONISTS AND INHIBITORS; DNA MICROARRAY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRIPLE NEGATIVE BREAST CANCER; TUMOR CELL CULTURE;

BIOMARKERS, TUMOR; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, ARYL HYDROCARBON; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; TRIPLE NEGATIVE BREAST NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 84903169173     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0100103     Document Type: Article

References (36)

1. Poland A, Knutson JC (1982) 2,3,7,8-tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity. Annu Rev Pharmacol Toxicol 22: 517-554.
2. Swanson HI, Bradfield CA (1993) The AH-receptor: genetics, structure and function. Pharmacogenetics 3: 213-230. (Pubitemid 23333091)
3. Callero MA, Loaiza-Perez AI (2011) The role of aryl hydrocarbon receptor and crosstalk with estrogen receptor in response of breast cancer cells to the novel antitumor agents benzothiazoles and aminoflavone. Int J Breast Cancer 2011: 923250.
4. Eguchi H, Ikuta T, Tachibana T, Yoneda Y, Kawajiri K (1997) A nuclear localization signal of human aryl hydrocarbon receptor nuclear translocator/hypoxia-inducible factor 1beta is a novel bipartite type recognized by the two components of nuclear pore-targeting complex. J Biol Chem 272: 17640-17647. (Pubitemid 27311200)
5. Kanno Y, Miyama Y, Takane Y, Nakahama T, Inouye Y (2007) Identification of intracellular localization signals and of mechanisms underlining the nucleocytoplasmic shuttling of human aryl hydrocarbon receptor repressor. Biochem Biophys Res Commun 364: 1026-1031. (Pubitemid 350087903)
6. Nebert DW, Dalton TP, Okey AB, Gonzalez FJ (2004) Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer. J Biol Chem 279: 23847-23850. (Pubitemid 38725238)
7. Schlezinger JJ, Liu D, Farago M, Seldin DC, Belguise K, et al. (2006) A role for the aryl hydrocarbon receptor in mammary gland tumorigenesis. Biol Chem 387: 1175-1187. (Pubitemid 44402063)
8. Wong PS, Li W, Vogel CF, Matsumura F (2009) Characterization of MCF mammary epithelial cells overexpressing the Arylhydrocarbon receptor (AhR). BMC Cancer 9: 234.
9. Goode GD, Ballard BR, Manning HC, Freeman ML, Kang Y, et al. (2013) Knockdown of aberrantly upregulated aryl hydrocarbon receptor reduces tumor growth and metastasis of MDA-MB-231 human breast cancer cell line. Int J Cancer 133: 2769-2780.
10. Moennikes O, Loeppen S, Buchmann A, Andersson P, Ittrich C, et al. (2004) A constitutively active dioxin/aryl hydrocarbon receptor promotes hepatocarcinogenesis in mice. Cancer Res 64: 4707-4710. (Pubitemid 38924510)
11. Andersson P, McGuire J, Rubio C, Gradin K, Whitelaw ML, et al. (2002) A constitutively active dioxin/aryl hydrocarbon receptor induces stomach tumors. Proc Natl Acad Sci U S A 99: 9990-9995. (Pubitemid 34831160)
12. Eltom SE, Gasmelseed A, Saoudi-Guentri D (2006) The aryl hydrocarbon receptor is over-expressed and constitutively activated in advanced breast carcinoma. Proc Amer Assoc Cancer Research 47.
13. Brooks J, Eltom SE (2011) Malignant transformation of mammary epithelial cells by ectopic overexpression of the aryl hydrocarbon receptor. Curr Cancer Drug Targets 11: 654-669.
14. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, et al. (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4: 249-264.
15. Zhang B, Kirov S, Snoddy J (2005) WebGestalt: an integrated system for exploring gene sets in various biological contexts. Nucleic Acids Res 33: W741-748. (Pubitemid 44530021)
16. Gao J, Ade AS, Tarcea VG, Weymouth TE, Mirel BR, et al. (2009) Integrating and annotating the interactome using the MiMI plugin for cytoscape. Bioinformatics 25: 137-138.
17. Dale YR, Eltom SE (2006) Calpain mediates the dioxin-induced activation and down-regulation of the aryl hydrocarbon receptor. Mol Pharmacol 70: 1481-1487.
18. Opitz CA, Litzenburger UM, Sahm F, Ott M, Tritschler I, et al. (2011) An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor. Nature 478: 197-203.
19. Schwarcz R, Bruno JP, Muchowski PJ, Wu HQ (2012) Kynurenines in the mammalian brain: when physiology meets pathology. Nat Rev Neurosci 13: 465-477.
20. Lee HJ, Bach JH, Chae HS, Lee SH, Joo WS, et al. (2004) Mitogen-activated protein kinase/extracellular signal-regulated kinase attenuates 3-hydroxykynurenine-induced neuronal cell death. J Neurochem 88: 647-656. (Pubitemid 38140209)
21. Hattrup CL, Gendler SJ (2006) MUC1 alters oncogenic events and transcription in human breast cancer cells. Breast Cancer Res 8: R37.
22. Ning Y, Lenz HJ (2012) Targeting IL-8 in colorectal cancer. Expert Opin Ther Targets.
23. Xie K (2001) Interleukin-8 and human cancer biology. Cytokine Growth Factor Rev 12: 375-391.
24. Ma O, Cai WW, Zender L, Dayaram T, Shen J, et al. (2009) MMP13, Birc2 (cIAP1), and Birc3 (cIAP2), amplified on chromosome 9, collaborate with p53 deficiency in mouse osteosarcoma progression. Cancer Res 69: 2559-2567.
25. Dai Y, Dent P, Grant S (2003) Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) promotes mitochondrial dysfunction and apoptosis induced by 7-hydroxystaurosporine and mitogen-activated protein kinase kinase inhibitors in human leukemia cells that ectopically express Bcl-2 and Bcl-xL. Mol Pharmacol 64: 1402-1409. (Pubitemid 37532230)
26. Cogswell PC, Guttridge DC, Funkhouser WK, Baldwin AS, Jr. (2000) Selective activation of NF-kappa B subunits in human breast cancer: potential roles for NF-kappa B2/p52 and for Bcl-3. Oncogene 19: 1123-1131. (Pubitemid 30157541)
27. Partanen L, Staaf J, Tanner M, Tuominen VJ, Borg A, et al. (2012) Amplification and overexpression of the ABCC3 (MRP3) gene in primary breast cancer. Genes Chromosomes Cancer 51: 832-840.
28. O'Brien C, Cavet G, Pandita A, Hu X, Haydu L, et al. (2008) Functional genomics identifies ABCC3 as a mediator of taxane resistance in HER2-amplified breast cancer. Cancer Res 68: 5380-5389.
29. Li ZH, Spektor A, Varlamova O, Bresnick AR (2003) Mts1 regulates the assembly of nonmuscle myosin-IIA. Biochemistry 42: 14258-14266. (Pubitemid 37499423)
30. Ismail TM, Zhang S, Fernig DG, Gross S, Martin-Fernandez ML, et al. (2010) Self-association of calcium-binding protein S100A4 and metastasis. J Biol Chem 285: 914-922.
31. Miyazaki K, Matsuda S, Ichigotani Y, Takenouchi Y, Hayashi K, et al. (2000) Isolation and characterization of a novel human gene (NESH) which encodes a putative signaling molecule similar to e3B1 protein. Biochim Biophys Acta 1493: 237-241.
32. Cerutti JM, Delcelo R, Amadei MJ, Nakabashi C, Maciel RM, et al. (2004) A preoperative diagnostic test that distinguishes benign from malignant thyroid carcinoma based on gene expression. J Clin Invest 113: 1234-1242. (Pubitemid 38544109)
33. Salcedo R, Ponce ML, Young HA, Wasserman K, Ward JM, et al. (2000) Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression. Blood 96: 34-40. (Pubitemid 30456447)
34. Low-Marchelli JM, Ardi VC, Vizcarra EA, van Rooijen N, Quigley JP, et al. (2013) Twist1 induces CCL2 and recruits macrophages to promote angiogenesis. Cancer Res 73: 662-671.
35. Stamatovic SM, Keep RF, Mostarica-Stojkovic M, Andjelkovic AV (2006) CCL2 regulates angiogenesis via activation of Ets-1 transcription factor. J Immunol 177: 2651-2661. (Pubitemid 44201024)
36. Fondevila C, Metges JP, Fuster J, Grau JJ, Palacin A, et al. (2004) p53 and VEGF expression are independent predictors of tumour recurrence and survival following curative resection of gastric cancer. Br J Cancer 90: 206-215. (Pubitemid 38174963)